[cmsmasters_row data_width=”boxed” data_padding_left=”3″ data_padding_right=”3″ data_top_style=”default” data_bot_style=”default” data_color=”default” data_bg_position=”top center” data_bg_repeat=”no-repeat” data_bg_attachment=”scroll” data_bg_size=”cover” data_bg_parallax_ratio=”0.5″ data_padding_top=”0″ data_padding_bottom=”50″][cmsmasters_column data_width=”1/1″][cmsmasters_text]

 

Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron

David H. Henry,1* Naomi V. Dahl,2 and Michael A. Auerbach3

 

 

[/cmsmasters_text][cmsmasters_text animation_delay=”0″]

[pdf-embedder url=”https://awgp.pt/wp-content/uploads/2019/09/Thrombocytosis-and-venous-thromboembolism-in-cancer-patients-with-chemotherapy-induced-anemia-may-be-related-to-ESA-Henry-2011.pdf” title=”Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA (Henry 2011)”]

[/cmsmasters_text][/cmsmasters_column][cmsmasters_column data_width=”1/1″][/cmsmasters_column][/cmsmasters_row]